The Food and Drug Administration has today awarded $2 million to support two regional Centers of Excellence in Regulatory Science and Innovation.
The centers will be based at the University of Maryland and Georgetown University, and will focus on science and training needed to modernize and improve the way drugs and medical devices are reviewed and evaluated.
“These partnerships represent a critical, necessary and creative investment — one that will benefit not just FDA and academia, but also American consumers and industry,” said Jesse L. Goodman, the FDA’s chief scientist. “The Centers of Excellence will create new scientific research, training and staff exchange opportunities for FDA and leading area institutions.”
Just this past summer, the agency released its plan for “Advancing Regulatory Science at FDA,” and recently announced a related innovation initiative, “Driving Biomedical Innovation: Initiatives for Improving Products for Patients.”